AGN News and Press, Allergan plc From 07/10/19

I'm bullish on AbbVie ( ABBV ). It remains one of my largest pharma stocks, and I'm willing to add more, should the opportunity present itself. And I believe that it now has, and may even improve going forward. In this article, we'll take an updated look at the proposed merger between AbbVie...

There’s nothing on Wall Street that will bring you more ridicule in real time, and praise in good time, than buying low. The guy who buys at the bottom is always catching a falling knife while being eye-rolled by everyone else. Somebody’s got to do it though. Otherwise, there wou...

DUBLIN , July 9, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the company will present 29 abstracts at the 61 st American Headache Society (AHS) Meeting, including one late-breaking podium presentation, five oral podium presentations and 23 poster presentations. The...

The summer holiday season has begun but stocks, despite taking a breather following Trump's surprise exit of the U.S. - China trade negotiations, have resumed their upward trend and set new records towards the end of the month. In terms of buying and selling it was a rather quiet month for m...

Biopharma and biotech players are mostly in the red (again) ahead of an expected executive order from President Trump aimed at corralling U.S. drug prices. Specifically, the order will contain a "favored nation" clause that will be the basis for Medicare reimbursement, i.e., the reimbursem...

Merger activity decreased last week with three new deals announced and six pending deals closing. Deal Statistics: New Deals: The acquisition of Genesee & Wyoming (GWR) by affiliates of Brookfield Infrastructure and GIC (BIP) for $8.4 billion or $112.00 per share in cash. We...

Allergan (NYSE: AGN ) alleges that a proposed generic version of a treatment for high blood pressure from Ajanta infringes on its patent for Bystolic, Bloomberg reports, citing the complaint filed in federal court in Wilmington, DE. More news on: Allergan plc, Healthcare stocks news, R...

AbbVie ( ABBV ) had entered into a deal to acquire Allergan ( AGN ) for $63 billion, which would be $188 a share in cash and stock. This was a huge premium of 45% over the closing price of $129.57 on Monday, June 25, 2019. AbbVie's stock tanked on this news, closing lower by 16%. In my...

(Source: imgflip ) Due to reader requests, I've decided to break up my weekly "Best Dividend Stocks To Buy This Week" series into two parts. One will be the weekly watchlist article (with the best ideas for new money at any given time). The other will be a portfolio update. To also ma...

In recent weeks I’ve written several pieces highlighting the importance of holding cash. I’ve mentioned that the market has rallied back to all-time highs and attractive values are difficult to come by. I’ve said that patience is key to value investing. The same thing goes...